- Quote, Chart, News
- Snapshot
- Company Report
- Quotes
- Charts
- Key Developments
Recent News- Research
- SEC Filings
- Advisor FYI
- CAPS
- StockScouter
- Earnings Estimates
- Analyst Ratings
- Financial Results
- Insider Trading
- Ownership
- Message Board
- Guided Research
- Research Wizard
- Find Stocks
- Stock Screener
- Stock Power Searches
- Top-Rated Stocks
- Related Links
- Quote Watchlist
- Expert Picks
- E-mail & Alerts
- IPO Center
- Message Boards
- Capital Gains Analysis
News resources
| Incyte Corp (INCY) | 2 stories... |
| American International Group Inc (AIG) | 2 stories... |
| LM Ericsson Telephone ADR Reptg 1 Ord Shs Class B (ERIC) | 2 stories... |
| New York Times Co (NYT) | 1 story... |
| Ford Motor Co (F) | 1 story... |
| advertisement |
Seattle Genetics: All Recent News
- Seattle Genetics gets $12 million in Astellas deal 11/23/2009
- BOTHELL, Wash. (AP) - Seattle Genetics Inc. said Monday it will receive $12 million as part of an expanded collaboration with Astellas unit Agensys Inc. Associated Press
- Seattle Genetics and Agensys, an Affiliate of Astellas, Expand... 11/23/2009
- Seattle Genetics, Inc. (Nasdaq: SGEN) and Agensys, Inc., an affiliate of Astellas, announced today an expansion of the companies’ antibody-drug conjugate (ADC) collaboration. Under the amended... Business Wire
- Market Report -- In Play (SGEN) 11/23/2009
- Seattle Genetics and Agensys, an Affiliate of Astellas, Expand Antibody-Drug Conjugate Collaboration Co announces an expansion of the companies' antibody-drug conjugate collaboration. Under the... Briefing.com
- Seattle Genetics Initiates Phase I Clinical Trial of... 11/16/2009
- Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that it has initiated a phase I clinical trial of SGN-75 for metastatic renal cell carcinoma and relapsed and refractory non-Hodgkin lymphoma. Business Wire
- Seattle Genetics to Present at Upcoming Investor Conferences 10/27/2009
- Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that management will present at two upcoming investor conferences. The presentations will be webcast live and available for replay from Seattle... Business Wire
- Seattle Genetics Highlights Pipeline Progress and Reports... 10/22/2009
- Seattle Genetics, Inc. (Nasdaq:SGEN) today reported financial results for the third quarter and nine months ended September 30, 2009. The company also highlighted recent product development... Business Wire
- Seattle Genetics to Host Conference Call and Webcast... 10/15/2009
- Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that it will report its third quarter 2009 financial results on Thursday, October 22, 2009, after the close of financial markets. Following the... Business Wire
- Seattle Genetics Names Head of Commercial and Announces... 10/13/2009
- Seattle Genetics, Inc. (Nasdaq: SGEN) today announced the appointment of Bruce J. Seeley as Executive Vice President, Commercial. Mr. Seeley brings more than 18 years of experience in oncology drug... Business Wire
- Seattle Genetics Announces Discontinuation of Dacetuzumab... 10/5/2009
- Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that it has discontinued the SeaGen MARINER clinical trial based on a determination that the trial would be unlikely to meet its primary endpoint... Business Wire
- Seattle Genetics to Present at JMP Securities Healthcare Focus... 9/29/2009
- Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that company management will present at the Fourth Annual JMP Securities Healthcare Focus Conference on Monday, October 5, 2009, at 8:30 a.m. Business Wire
- Seattle Genetics Introduces Novel Technology for Empowering... 9/22/2009
- Seattle Genetics, Inc. (Nasdaq:SGEN) announced today the introduction of its sugar engineered antibody (SEA) technology, a novel approach to increasing the potency of monoclonal antibodies through... Business Wire
- Seattle Genetics to Present at UBS Global Life Sciences Conference 9/17/2009
- Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that Clay B. Siegall, Ph.D., President and Chief Executive Officer, will present at the 2009 UBS Global Life Sciences Conference on Tuesday,... Business Wire
- Seattle Genetics Achieves Milestone Under Antibody-Drug... 9/8/2009
- Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Bayer Schering Pharma AG, Germany. The milestone was... Business Wire
- Seattle Genetics to Present at Upcoming Investor Conferences 9/3/2009
- Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that management will present at the following investor conferences. The presentations will be webcast live and available for replay from Seattle... Business Wire
- More News
- Market Report
- News by Symbol
- Today's Investing Articles
- Breaking News
- News by Topic
- News by Industry
- MSNBC News
- Data providers
- Copyright © 2009 Thomson Reuters. Click for Restrictions.
- Quotes supplied by Interactive Data Real-Time Services.